NCT04689243

Brief Summary

Skin ulcer is a common disease with complicated etiopathogenes, which makes it hard to be cured. It has been reported that photodynamic therapy (PDT) can be used to treat skin ulcers which were caused by different diseases. However, PDT is an expensive treatment and patients always experience obvious pain during or after the treatment, which hinders the application of PDT in skin ulcer. Our previous study found that PDT using a low concentration of 5-Aminolevulinic acid (ALA) could promote the healing of skin ulcer without obvious adverse reactions, which suggests us that low concentration ALA-PDT might be an efficient and cost effective treatment in skin ulcer. To further investigate the use of low concentration ALA-PDT in skin ulcer, we plan to recruit patients with skin ulcers caused by different diseases, and divide these patients into different groups according to their causes of disease, and then treat them using low concentration ALA-PDT to observe the healing process of skin ulcer. This study could further optimize and promote the use of low concentration ALA-PDT in skin ulcer.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

December 23, 2020

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 26, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

December 30, 2020

Status Verified

December 1, 2020

Enrollment Period

2 years

First QC Date

December 23, 2020

Last Update Submit

December 29, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • ulcer area size

    The ulcer area size was measured

    Change from Baseline ulcer area size at 24 hours after the last treatment.

Secondary Outcomes (1)

  • total bacterial load

    Change from Baseline total bacterial load at 24 hours after the last treatment.

Study Arms (2)

ALA-PDT

EXPERIMENTAL
Procedure: ALA-PDT

red light

OTHER
Procedure: red light

Interventions

ALA-PDTPROCEDURE

Low concentration ALA-PDT, 3 times a week.

ALA-PDT
red lightPROCEDURE

red light, 3 times a week.

red light

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • chronic skin wounds that involved the dermis and did not heal in three months or did not exhibit a tendency toward healing

You may not qualify if:

  • allergies to photosensitizers and their solvents, serious medical illnesses, such as severe heart disease, severe liver or kidney dysfunction, systemic infection or any concomitant infection that would require treatment with an additional antimicrobial agent, the use of topical or systemic antibiotics within one month prior to treatment. Pregnant or lactating women were also excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sichuan Provincial People's Hospital

Chengdu, Sichuan, 610031, China

RECRUITING

MeSH Terms

Conditions

Skin Ulcer

Interventions

Red Light

Condition Hierarchy (Ancestors)

Skin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

LightElectromagnetic RadiationElectromagnetic PhenomenaMagnetic PhenomenaPhysical PhenomenaOptical PhenomenaRadiationRadiation, Nonionizing

Central Study Contacts

Yujie Mao, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

December 23, 2020

First Posted

December 30, 2020

Study Start

January 1, 2019

Primary Completion

December 26, 2020

Study Completion

December 30, 2020

Last Updated

December 30, 2020

Record last verified: 2020-12

Locations